...notice by Dec. 31, 2021, recognizing that Bonsity teriparatide is therapeutically equivalent to osteoporosis drug Forteo...

...Laboratories. His drug development successes include diabetes drug Humalog insulin lispro and osteoporosis drug Forteo teriparatide...

...siponimod Treat secondary progressive multiple sclerosis (SPMS) MAA action YE19 Pfenex Inc . (NYSE-M:PFNX) biosimilar teriparatide...

...a 12-month treatment course based on the supporting clinical trials on its U.S. label. Forteo teriparatide...

...7 PDUFA date for PF708, its biosimilar of Forteo teriparatide to treat osteoporosis. Lilly markets Forteo...

...7 PDUFA date for PF708, its biosimilar of Forteo teriparatide to treat osteoporosis. Lilly markets Forteo...

...NDA to FDA for lead candidate PF708, which is a biosimilar of osteoporosis drug Forteo teriparatide...

...in sales. The price cut did allow Tymlos to replace Eli Lilly and Co.’s Forteo teriparatide...

...that first quarter sales of osteoporosis drug Forteo teriparatide fell 10% year-over-year to $313.2 million. Forteo...
...the 2018 formulary for Express Scripts Holding Co. (NASDAQ:ESRX) just months after its launch, knocking Forteo...
...onto the excluded list (see BioCentury, Aug. 11, 2017) . Consensus figures provided by FactSet. Mary Romeo abaloparatide-SC Basaglar dulaglutide empagliflozin Forteo insulin...

...or no competition.” The new guidance is aimed specifically at ANDAs for glucagon, liraglutide, nesiritide, teriparatide...